Literature DB >> 11241273

Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes.

M B Delgado1, I Clark-Lewis, P Loetscher, H Langen, M Thelen, M Baggiolini, M Wolf.   

Abstract

The CXC chemokine stromal cell-derived factor (SDF)-1 is produced constitutively in different tissues. It is the only known ligand for CXCR4, which is widely expressed in leukocytes and in some tissue cells, and acts as coreceptor for X4 HIV strains. Because of the general interest in the mechanisms that regulate the activity of constitutively expressed chemokines, we have studied the inactivation of SDF-1 in cells that bear CXCR4. Here we show that B lymphocytes, NK cells and, to a lesser extent, T lymphocytes inactivate SDF-1 by N-terminal processing. Inactivation is due to cathepsin G which is associated with the membrane of lymphocytes and rapidly cleaves off five N-terminal residues by acting on the Leu(5)-Ser(6) bond yielding SDF-1(6-67). Processing was observed with intact cells, cell membrane preparations and soluble cathepsin G obtained by extraction of the membranes with Triton X-100. Cathepsin G is released by neutrophils and monocytes and binds on the surface of lymphocytes by an apparently saturable process. Analysis of the product obtained, the time course and the sensitivity to inhibitors shows that cathepsin G is the only protease involved. Conversion of SDF-1 to SDF-1(6-67) was complete within minutes to 1-2 h depending on the enzyme source, and was abrogated by inhibitors of serine proteases and chymostatin. Diprotin A, an inhibitor of dipeptidyl peptidase IV, was without effect. Owing to its availability on the surface of SDF-1-responsive cells and its rapid effect, cathepsin G is likely to play a significant role in down-regulating SDF-1 activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241273     DOI: 10.1002/1521-4141(200103)31:3<699::aid-immu699>3.0.co;2-6

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

Review 1.  Peeking into the secret life of neutrophils.

Authors:  Jackson LiangYao Li; Lai Guan Ng
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

4.  Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance.

Authors:  Satish Khurana; Lia Margamuljana; Chacko Joseph; Sarah Schouteden; Shannon M Buckley; Catherine M Verfaillie
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

5.  FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Giovanna Tosato
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

6.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.

Authors:  Jean-Pierre Lévesque; Jean Hendy; Yasushi Takamatsu; Paul J Simmons; Linda J Bendall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 7.  Proteolytic regulatory mechanism of chemerin bioactivity.

Authors:  Xiao-Yan Du; Lawrence L K Leung
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-12       Impact factor: 3.848

Review 8.  CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Authors:  Magda Kucia; Kacper Jankowski; Ryan Reca; Marcin Wysoczynski; Laura Bandura; Daniel J Allendorf; Jin Zhang; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.

Authors:  Yan-Xi Sun; Elisabeth A Pedersen; Yusuke Shiozawa; Aaron M Havens; Younghun Jung; Jingcheng Wang; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Exp Metastasis       Date:  2008-06-18       Impact factor: 5.150

10.  SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer.

Authors:  Bijan Khademi; Mahboobeh Razmkhah; Nasrollah Erfani; Marjan Gharagozloo; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.